Drugs / RUT058-60
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02280395 | Oct 2014 → Jun 2015 | periprosthetic joint infection, prosthesis-related infectious disease | Pulmatrix Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RUT058-60 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280395 ↗ |
| Route | Other | “as an intra-cavity lavage” NCT02280395 ↗ |